Thermidas Oy

16/09/2025

A Finnish care home has adopted the Thermidas IRT-384 Tablet following a successful trial, and the results have been remarkable.

In September 2025, the care home reported zero new pressure injuries for over a year, thanks to the integration of thermal imaging into their daily routines.

Staff concluded that thermal imaging is currently the most effective tool for preventing pressure injuries.

---

Suomalainen hoivakoti pilotoi Thermidaksen IRT-384 lämpökuvaustablettia vuonna 2024 ja päätyi hankkimaan järjestelmän pysyvään käyttöön. Ensimmäinen vuoden tulokset ovat nyt selvillä.

Onnistuneen pilotin jälkeen lämpökuvantamisjärjestelmä integroitiin hoivakodin päivittäiseen hoitorutiiniin syksyllä 2024, jolloin hoivakodissa oli jatkuvasti n. 4–6 aktiivista painehaavaa.

Tulokset näkyivät välittömästi, ja ensimmäisen kuuden kuukauden aikana uusia aktiivisia painehaavoja ei syntynyt yhtäkään. Syksyllä 2025 tilanne katsastettiin uudelleen, jolloin tilanne oli pysynyt yhtä hyvänä. Lämpökuvantamisen aloittamisen jälkeen kyseisessä hoivakodissa ei ole syntynyt uusia aktiivisia painehaavoja yli vuoteen.

05/03/2025

We are thrilled to announce that Thermidas Oy has achieved a groundbreaking milestone. Our thermal imaging method has become the first of its kind in the world to receive Class IIa Medical Device CE certification.

Based on the latest clinical evaluation report, the product provides new insights into the analysis of diabetic foot ulcers, pressure injuries, vascular disorders, arthritis, skin cancer, and autonomic dysfunction in patients. These insights not only aid clinicians in making sound clinical decisions but may also empower patients with a greater awareness of their conditions, enabling them to actively participate in their own care.

This technology changes the paradigm in thermal imaging, providing unprecedented accuracy, speed, and cost-efficiency. With 17 years of dedicated development and comprehensive research, we have ensured the effectiveness and safety of our products, as required by the Medical Device Regulation (EU) 2017/745.

Thermidas is the first company globally to have CE marking for its thermal imaging product in Europe and FDA 510(k) clearance in the United States. This dual recognition positions us at the forefront of healthcare imaging technology, driving global advancements in medical practices.

29/01/2025

Valtakunnallisia Haavapäiviä vietetään tämän viikon torstaina ja perjantaina Helsingissä.

Tervetuloa osastolle B15 keskustelemaan Thermidaksen asiantuntijoiden kanssa!

10/01/2025

During our recent visit to Dubai, Abu Dhabi International Medical Services LLC, Novasvia, and Thermidas signed a partnership and distribution agreement for the following countries: the United Arab Emirates, Saudi Arabia, Egypt, Qatar, Jordan, Bahrain, Oman, Morocco, Iraq, and Lebanon.

15/11/2024

Thermidas is exhibiting at the National Care Home Conference organised by Scottish Care.

This year’s conference will bring together a diverse array of voices from across the care home sector, including industry experts, policymakers, and frontline caregivers.

Pressure injuries are a common problem in many care homes. Infrared thermography has great value of clinical application in daily pressure injury assessment (1). It can objectively and accurately detect pressure injuries 1 day before visual detection and is therefore able to guide prevention earlier than would otherwise be possible (2).



Sources:
(1) Fuman Cai, 2020. Application of infrared thermography in the early warning of pressure injury: a prospective observational study.
(2) Jiang et al, 2022. Application of an infrared thermography-based model to detect pressure injuries: a prospective cohort study

14/11/2024

Today is

World Diabetes Day is the world’s largest diabetes awareness campaign. It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin in 1921.

Globally, 537 million people are living with diabetes - that's about 1 in every 10 adults whose well-being is potentially being impacted by diabetes.

63 % of people with diabetes surveyed by the International Diabetes Federation say that the fear of developing diabetes-related complications affects their well-being.

Diabetic Foot Ulcers (DFU) are one of the most common complications, affecting up to 34 % of people living with diabetes.

To learn more about DFU prevention, visit https://thermidas.fi/applications/diabetic-foot-problems/

14/10/2024

Homeland Day in Deventer.

Thank you for the invitation and a great event!

Photos by Antonie Colijn

02/10/2024

Last week, Thermidas participated in HOMELAND day in Deventer.

HOMELAND wants to improve care to prevent amputations, save costs, and allow patients to maintain their quality of life for longer.

We got to conduct a usability study for the upcoming Thermidas Telehealth Solution and demonstrate the versatility of our thermal imaging ecosystem.

The results of the usability study will be published later.

11/09/2024

Thermography is emerging as a powerful tool for pain detection and management. This non-invasive, radiation-free imaging technique offers an intuitive way to visualize and quantify pain, providing valuable insights for both patients and healthcare providers.

In the realm of medical diagnostics, thermography is emerging as a powerful tool for pain detection and management. This non-invasive, radiation-free imaging

03/05/2024

"In this exclusive interview with Jouni Kyllönen, CEO at Thermidas, we learn about the intricacies of thermal imaging technology and its profound impact on improving the quality of care in care homes."

Read the entire exclusive interview:
https://carehomemagazine.co.uk/enhancing-care/

In this exclusive interview with Jouni Kyllönen, CEO at Thermidas, we learn about the intricacies of thermal imaging technology and […]

29/04/2024

Thermidas järjestää kansallisen Diabetes ja jalka -symposiumin yhteydessä oheistapahtuman, joka keskittyy lämpökuvantamisen käyttöön diabeetikon jalkaongelmien hoidossa.

Lämpökuvantaminen terveydenhuollossa -minisymposium ajoittuu ensimmäisen tapahtumapäivän iltaan. Päätapahtuman ohjelman loputtua voit jäädä kätevästi samaan osoitteeseen syventämään osaamistasi lämpökuvantamisen parissa.

Ilmoittaudu mukaan nyt - paikkoja on vain rajoiteusti.

https://thermidas.fi/fi/diabetes-ja-jalka-symposium-2024/

Thermidas järjestää kansallisen diabetes- ja jalkasymposiumin yhteydessä lämpökuvantamiseen keskittyvän, maksuttoman ennakkotapahtuman. Varaa paikkasi tänään.

29/04/2024

The podiatry students at Metropolia University of Applied Sciences (Metropolia Jalkaterapia) have been testing the Thermidas ThIR-A615 thermal imaging system.

"The students were very enthusiastic and interested in the device and had many ideas on how to use and benefit from it in the context of podiatry."

Tällä viikolla olemme testanneet Thermidaksen lämpökuvantamislaitetta heidän asiantuntijansa Frida Samuelssonin johdolla HyMy-kylän harjoittelussa.

Opiskelijat olivat laitteesta hyvin innostuneita ja kiinnostuneita ja heille syntyi monia ajatuksia laitteen käytöstä ja hyödyntämisestä jalkaterapian kontekstissa.

Laite on käytössä muun muassa muutamissa erikoissairaanhoidon paikoissa diabeetikoiden jalkakomplikaation varhaisessa tunnistamisessa, jossa nimenomaan jalkaterapeutti on tyypillisesti toteuttamassa lämpökuvantamista asiakkaalle.

Kiitos Frida tähän astisesta!